1
Supplementary Table 1: Relative quantification of released c/MAM O-glycan species.
Glycan structure
H+
Gal(β1-3)[NeuAc(α2-6)]GalNAc-ol
1
677.26
0.4
NeuAc(α2-3)Gal(β1-3)GalNAc-ol
1
677.26
1.0
Gal(β1-3)[Gal(β1-4)GlcNAc(β1-6)]GalNAc-ol
1
751.3
2.6
Gal(β1-3)[HexNAcGlcNAc(β1-6)]GalNAc-ol
1
792.32
1.1
Gal(β1-3)[Gal(β1-4)GlcNAc(β1-6)]GalNAc-ol + Fuc
1
897.36
0.5
NeuAc(α2-3)Gal(β1-3)[NeuAc(α2-6)]GalNAc-ol
1
968.36
37.9
NeuAc(α2-3)Gal(β1-3)[Gal(β1-4)GlcNAc(β1-6)]GalNAc-ol
1
1042.39
1.9
Gal(β1-3)[NeuAc(α2-3)Gal(β1-4)GlcNAc(β1-6)]GalNAc-ol
1
1042.39
11.3
NeuAc(α2-3)Gal(β1-3)[HexNAcGlcNAc(β1-6)]GalNAc-ol
1
1083.42
1.0
NeuAc(α2-3)Gal(β1-3)[NeuAc(α2-3)Gal(β1-4)GlcNAc(β1-6)]GalNAc-ol
2
667.24
39.3
NeuAc(α2-3)Gal(β1-3)[NeuAc(α2-3)Gal(β1-4)GlcNAc(β1-6)]GalNAc-ol + Sulf
2
707.26
3.0
monoisotopic mass
relative intensity [%]
2
1